GOLDMAN SACHS GROUP INC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q1 2019$208,000
+118.9%
35,567
-51.2%
0.00%
Q4 2018$95,000
-57.0%
72,909
+13.7%
0.00%
Q3 2018$221,000
-7.9%
64,144
+21.5%
0.00%
Q2 2018$240,000
+287.1%
52,776
+181.9%
0.00%
Q1 2018$62,000
-11.4%
18,722
+4.7%
0.00%
Q4 2017$70,000
-75.9%
17,882
-40.1%
0.00%
Q2 2017$291,000
+148.7%
29,878
+94.3%
0.00%
Q3 2016$117,000
-69.1%
15,378
-50.4%
0.00%
Q3 2015$379,000
-65.3%
31,027
-41.3%
0.00%
Q2 2015$1,092,000
+290.0%
52,870
+299.2%
0.00%
Q1 2015$280,000
-75.2%
13,244
-63.9%
0.00%
Q4 2014$1,128,000
+122.5%
36,652
+27.7%
0.00%
Q3 2014$507,00028,6980.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders